Stempeutics Research Pvt Ltd, Shirdi Sai Baba Cancer Hospital, Manipal, India.
Department of Dermatology, Venereology and Leprosy, Kasturba Medical College, Manipal, India.
J Cosmet Dermatol. 2022 Feb;21(2):814-826. doi: 10.1111/jocd.14145. Epub 2021 Apr 21.
Under-eye dark circles are a common condition observed in dermatology practice. Mesenchymal stromal cell-derived conditioned medium (MSC-CM) contains an array of growth factors and cytokines reported to promote periorbital rejuvenation and may be useful in removing the dark circle around the eyes.
The aim of the present study was to evaluate the safety and efficacy of developed bioactive formulation containing mesenchymal stromal cell-derived conditioned medium in reducing the under-eye dark circles.
PATIENTS/METHODS: We tested the safety profile of MSC-CM along with antioxidants, in vitro using human melanocytes cultures. The bioactive formulation containing MSC-CM was developed and tested for physicochemical parameters. The dermatological safety was evaluated by primary irritant patch-test under complete occlusion on healthy human subjects. To elucidate its safety and efficacy, monocentric, open-label, single-arm study was carried out in 20 Indian female subjects for the duration of 12 weeks. Parameters such as eye puffiness, radiance, skin smoothness, even skin tone, periorbital fine lines and wrinkles, crow's feet, whitening, pigmentation, skin tightening, and refreshing/soothing effect were used to investigate the rejuvenating property of the bioactive formulation.
Mesenchymal stromal cell-derived conditioned medium along with antioxidants decreased the melanin content compared to the CM alone in the melanocyte cultures. Besides, the bioactive formulation was safe and emerged as a non-irritant product. Improvement in the majority of the clinical parameters assessed through efficacy study was observed within 4 weeks of topical application of the formulation twice daily, and showed continued improvement for 12 weeks as evaluated by the dermatologists as well as self-assessment by the subjects.
The bioactive formulation containing MSC-CM was safe and effective in reducing the under-eye dark circles and was beneficial in improving the overall appearance of the eye area.
眼下黑眼圈是皮肤科常见病症。间充质基质细胞衍生的条件培养基(MSC-CM)中含有多种生长因子和细胞因子,据报道这些成分可促进眶周年轻化,可能有助于消除黑眼圈。
本研究旨在评估含有间充质基质细胞衍生的条件培养基的新型生物活性配方在减轻黑眼圈方面的安全性和疗效。
患者/方法:我们使用人黑素细胞培养物在体外测试了 MSC-CM 与抗氧化剂联合使用的安全性。开发了含有 MSC-CM 的生物活性配方,并对其理化参数进行了测试。通过在健康人体上进行完全封闭的原发性刺激性斑贴试验评估其皮肤学安全性。为了阐明其安全性和疗效,在 20 名印度女性中进行了为期 12 周的单中心、开放性、单臂研究。使用眼部肿胀、光泽度、皮肤光滑度、肤色均匀度、眶周细纹和皱纹、鱼尾纹、美白、色素沉着、皮肤紧致度和清爽/舒缓效果等参数来研究生物活性配方的年轻化特性。
与单独使用 CM 相比,MSC-CM 与抗氧化剂联合使用可降低黑素细胞中的黑色素含量。此外,生物活性配方安全且无刺激性。通过每天两次局部涂抹该配方,在 4 周内观察到大多数评估临床参数的改善,并且通过皮肤科医生评估和受试者自我评估,在 12 周内持续改善。
含有 MSC-CM 的生物活性配方在减轻黑眼圈方面安全且有效,并且有益于改善眼部整体外观。